FDA advisers have recommended Pfizer for children aged 5 to 11 years

The United States has thus moved closer to vaccinating children of this age, the AP noted. According to her, the FDA does not have to follow the recommendations of the expert advisory panel and is expected to make its own decision in the next few days. However, according to Reuters, the advisers’ recommendations are usually inspired.

If the FDA also recommends vaccine doses for younger children, the next step will be at the US Centers for Disease Control and Prevention (CDC) to issue a final verdict, specifying, for example, what age groups these doses would be intended for.

According to the AP, the FDA’s advisory panel voted unanimously, with one member abstaining. The benefits of covid-19 vaccine in this age group outweigh the potential risks.

Although the risk of a more severe course of covid-19 is lower in children than in the elderly, children between the ages of five and 11 do not avoid the more severe course of the disease. According to the AP, the country registers 8,300 hospitalizations of children with this disease and almost 100 deaths.

The child’s dose is one third of the amount of the vaccine that is recommended for people over 12 years of age. According to Pfizer and BioNTech, their vaccine is 90.7 percent effective in children aged five to 11, Reuters said.